Seeking more suitable treatment options, Mr. Alexander, a melanoma patient from Russia, traveled abroad and arrived at GoBroad Healthcare Group. He was evaluated and treated by Professor Jun Guo—Discipline Leader in melanoma, sarcoma, and genitourinary oncology, and one of China’s leading authorities in these fields.

After a comprehensive assessment, Professor Guo developed a personalized treatment plan for Mr. Alexander, which included the use of Tunlametinib, a drug currently approved and available only in China. While this option renewed his sense of hope, he remained concerned about potential side effects.

To support him, the GoBroad patient-service team arranged a peer-to-peer conversation with another Russian patient who had previously undergone a similar treatment at GoBroad. Their open 20-minute discussion in their shared native language provided clarity, eased anxiety, and strengthened Mr. Alexander’s confidence in the plan ahead.
Before departing, he expressed his gratitude by gifting the team a set of traditional Russian Matryoshka dolls—a warm symbol of trust and appreciation toward Professor Guo and GoBroad.

At GoBroad Healthcare Group, we are dedicated to providing global patients with reliable access to needed therapies, while delivering compassionate, culturally responsive support throughout every step of their medical journey.